miR‑133b Is a Potential Diagnostic Biomarker for Alzheimer's Disease and Has a Neuroprotective Role

Experimental and Therapeutic Medicine - Greece
doi 10.3892/etm.2019.7855
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

Serum miR-21 May Be a Potential Diagnostic Biomarker for Diabetic Nephropathy

Experimental and Clinical Endocrinology and Diabetes
Internal MedicineMedicineDiabetesMetabolismEndocrinology
2015English

ERRATUM: Acknowledgments Correction. Cell-Free miR-27a, a Potential Diagnostic and Prognostic Biomarker for Gastric Cancer

Genomics and Informatics
EvolutionEcologyGeneticsSystematicsHealth InformaticsBehavior
2015English

Circulating miR-95 Is a Potential Biomarker of Chronic Lymphocytic Leukemia

Research in Molecular Medicine (RMM)
2019English

Resveratrol Nanoparticles Are Neuroprotective in Vitro Suggesting a Potential to Cure Glaucoma and Alzheimer's Disease

Acta Ophthalmologica
MedicineOphthalmology
2018English

Cardiac Myosin Binding Protein-C Is a Potential Diagnostic Biomarker for Myocardial Infarction

Journal of Molecular and Cellular Cardiology
Cardiovascular MedicineMolecular BiologyCardiology
2012English

The Amyloid-Β Oligomer Count in Cerebrospinal Fluid Is a Biomarker for Alzheimer's Disease

Journal of Alzheimer's Disease
GerontologyClinical PsychologyMental HealthPsychiatryGeriatricsMedicineNeuroscience
2013English

MiR-30a: A Novel Biomarker and Potential Therapeutic Target for Cancer

Journal of Oncology
Oncology
2018English

Still Debating a Cause and Diagnostic Criteria for Alzheimer's Disease

Journal of Cellular and Molecular Medicine
Molecular MedicineCell Biology
2007English

Nicotine as a Potential Neuroprotective Agent for Parkinson's Disease

Movement Disorders
Neurology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy